TrialThe Lancet. Oncology2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study.
Jean-Pierre J Issa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
146 papers cite itlatest 60 shown
this paperpooled ittrialcites it